BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23386607)

  • 21. Proteolytic processing regulates Toll-like receptor 3 stability and endosomal localization.
    Qi R; Singh D; Kao CC
    J Biol Chem; 2012 Sep; 287(39):32617-29. PubMed ID: 22865861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequence determinants in the cathelicidin LL-37 that promote inflammation via presentation of RNA to scavenger receptors.
    Kulkarni NN; O'Neill AM; Dokoshi T; Luo EWC; Wong GCL; Gallo RL
    J Biol Chem; 2021 Jul; 297(1):100828. PubMed ID: 34048712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ISG56 is involved in CXCL10 expression induced by TLR3 signaling in BEAS-2B bronchial epithelial cells.
    Shiratori T; Imaizumi T; Hirono K; Kawaguchi S; Matsumiya T; Seya K; Tasaka S
    Exp Lung Res; 2020; 46(6):195-202. PubMed ID: 32363951
    [No Abstract]   [Full Text] [Related]  

  • 24. Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1.
    Wan M; Godson C; Guiry PJ; Agerberth B; Haeggström JZ
    FASEB J; 2011 May; 25(5):1697-705. PubMed ID: 21307335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH.
    de Bouteiller O; Merck E; Hasan UA; Hubac S; Benguigui B; Trinchieri G; Bates EE; Caux C
    J Biol Chem; 2005 Nov; 280(46):38133-45. PubMed ID: 16144834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Citrullination alters immunomodulatory function of LL-37 essential for prevention of endotoxin-induced sepsis.
    Koziel J; Bryzek D; Sroka A; Maresz K; Glowczyk I; Bielecka E; Kantyka T; Pyrć K; Svoboda P; Pohl J; Potempa J
    J Immunol; 2014 Jun; 192(11):5363-72. PubMed ID: 24771854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The RNA-binding protein Mex3B is a coreceptor of Toll-like receptor 3 in innate antiviral response.
    Yang Y; Wang SY; Huang ZF; Zou HM; Yan BR; Luo WW; Wang YY
    Cell Res; 2016 Mar; 26(3):288-303. PubMed ID: 26823206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LL-37 and Double-Stranded RNA Synergistically Upregulate Bronchial Epithelial TLR3 Involving Enhanced Import of Double-Stranded RNA and Downstream TLR3 Signaling.
    Bodahl S; Cerps S; Uller L; Nilsson BO
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clathrin-mediated endocytic pathway participates in dsRNA-induced IFN-beta production.
    Itoh K; Watanabe A; Funami K; Seya T; Matsumoto M
    J Immunol; 2008 Oct; 181(8):5522-9. PubMed ID: 18832709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antimicrobial peptide LL-37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils--implications for asthma.
    Sun J; Dahlén B; Agerberth B; Haeggström JZ
    Allergy; 2013 Mar; 68(3):304-11. PubMed ID: 23330796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cathelicidin LL-37 Affects Surface and Intracellular Toll-Like Receptor Expression in Tissue Mast Cells.
    Agier J; Brzezińska-Błaszczyk E; Żelechowska P; Wiktorska M; Pietrzak J; Różalska S
    J Immunol Res; 2018; 2018():7357162. PubMed ID: 29670923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pleurocidin, a novel antimicrobial peptide, induces human mast cell activation through the FPRL1 receptor.
    Pundir P; Catalli A; Leggiadro C; Douglas SE; Kulka M
    Mucosal Immunol; 2014 Jan; 7(1):177-87. PubMed ID: 23839065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface Toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness.
    Bugge M; Bergstrom B; Eide OK; Solli H; Kjønstad IF; Stenvik J; Espevik T; Nilsen NJ
    J Biol Chem; 2017 Sep; 292(37):15408-15425. PubMed ID: 28717003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37.
    Carretero M; Escámez MJ; García M; Duarte B; Holguín A; Retamosa L; Jorcano JL; Río MD; Larcher F
    J Invest Dermatol; 2008 Jan; 128(1):223-36. PubMed ID: 17805349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes.
    Li K; Chen Z; Kato N; Gale M; Lemon SM
    J Biol Chem; 2005 Apr; 280(17):16739-47. PubMed ID: 15737993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proinflammatory proteases liberate a discrete high-affinity functional FPRL1 (CCR12) ligand from CCL23.
    Miao Z; Premack BA; Wei Z; Wang Y; Gerard C; Showell H; Howard M; Schall TJ; Berahovich R
    J Immunol; 2007 Jun; 178(11):7395-404. PubMed ID: 17513790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scavenger receptor SREC-I promotes double stranded RNA-mediated TLR3 activation in human monocytes.
    Murshid A; Gong J; Ahmad R; Borges TJ; Calderwood SK
    Immunobiology; 2015 Jun; 220(6):823-32. PubMed ID: 25641411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cathelicidin LL-37 induces time-resolved release of LTB4 and TXA2 by human macrophages and triggers eicosanoid generation in vivo.
    Wan M; Soehnlein O; Tang X; van der Does AM; Smedler E; Uhlén P; Lindbom L; Agerberth B; Haeggström JZ
    FASEB J; 2014 Aug; 28(8):3456-67. PubMed ID: 24736410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells.
    Matsukura S; Kokubu F; Kurokawa M; Kawaguchi M; Ieki K; Kuga H; Odaka M; Suzuki S; Watanabe S; Takeuchi H; Kasama T; Adachi M
    Clin Exp Allergy; 2006 Aug; 36(8):1049-62. PubMed ID: 16911361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of T Cells Reactive to the Cathelicidin Antimicrobial Peptide LL-37 in Acute Coronary Syndrome and Plaque Calcification.
    Chernomordik F; Cercek B; Lio WM; Mihailovic PM; Yano J; Herscovici R; Zhao X; Zhou J; Chyu KY; Shah PK; Dimayuga PC
    Front Immunol; 2020; 11():575577. PubMed ID: 33123157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.